Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Etf Ticker Symbol | Market | Type |
|---|---|---|---|
| Strategic Trust Kelly CRISPR and Gene Editing Technology ETF | XDNA | NASDAQ | Exchange Traded Fund |
| Price Change | Change Percent | Etf Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 7.38 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.38 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 5.87 - 10.049 |
| Last Trade Time | Type | Quantity | Etf Price | Currency |
|---|---|---|---|---|
| - | 0 | 7.38 | USD |
Strategic Trust Kelly CRISPR and Gene Editing Technology ETF Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.58M | - | - | - | 25.51 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Strategic Trust Kelly CR...
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
XDNA Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 6.44 | 7.80 | 6.285 | 7.21 | 6,680 | 0.94 | 14.60% |
| 1 Year | 8.94 | 10.049 | 5.87 | 8.12 | 3,347 | -1.56 | -17.45% |
| 3 Years | 14.76 | 14.99 | 5.87 | 11.18 | 4,418 | -7.38 | -50.00% |
| 5 Years | 14.76 | 14.99 | 5.87 | 11.18 | 4,418 | -7.38 | -50.00% |
| The Kelly CRISPR & Gene Editing Technology ETF (the Fund) seeks to track the total return performance, before fees and expenses, of the Strategic CRISPR & Gene Editing Technology Index (the Index). The Fund employs a passive management (or indexing) investment approach designed to track the total return performance, before fees and expenses, of the Index. The Index is based on a proprietary methodology developed and maintained by Strategic Indexes, LLC (the Index Provider), an affiliate of Kelly Strategic Management, LLC, the Funds investment adviser (the Adviser). Unlike many investment companies, the Fund does not try to beat the Index and does not seek temporary defensive positions when markets decline or appear overvalued other than those indicated in the Index. |
